Pyrido(3,2-d)pyrimidine derivatives represented by the structural formula (I):
wherein:
R
4
is hydrogen, and
R
1
, R
2
and R
3
together provide a specific substitution pattern,
pharmaceutical acceptable addition salts, stereochemical isomeric forms, N-oxides, solvates and pro-drugs thereof, are useful in the treatment of hepatitis C.
结构式(I)所代表的
吡啶并(3,2-d)
嘧啶衍
生物:其中:R4为
氢,且R1、R2和R3共同提供一种特定的取代模式,其药用可接受的加盐物、立体
化学异构体形式、N-
氧化物、溶剂合物和前药,可用于治疗丙型肝炎。